The Slovak Association of Research Based Pharmaceutical Companies (SAFS) has elected its new executive board. Paul Trnovec from GlaxoSmithKline was elected as the new chair of the board. Other board members are: Daniel Weber from Novartis, who is also the board vice-chair, Miroslav Lednar from Sanofi-Aventis, Dana Boehmova from Eli Lilly and Klaus Mittmann from Bayer. Mr. Weber and Ms Boehmova will also be in charge of drug policy, Mr. Lednar will focus on the subject of ethics in marketing, whilst Mr. Mittmann will oversee SAFS activities in the area of public relations and relationships with patients' organisations.
The newly elected chair has said that in 2010 the Association will continue its efforts to make the latest innovative medicines accessible to Slovak patients. It will also work on enhancing ethical behaviour in marketing activities carried out by pharmaceutical companies and building the value of innovative medicines in the eyes of experts and the lay public.
SAFS, founded in 1997, includes international pharmaceutical companies with their research and development of innovative medicines present in the Slovak drug market. Currently, SAFS associates 19 pharmaceutical companies.
1 year subscription to internet service providing market news and analytical articles
Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
12-month subscription (26 issues of biweekly news)
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
PMR Online Access
Browse and search in our archive »
Subscribe to PMR RSS NEWS channels » 
